News

More News

Two Faculty Win Vagelos Precision Medicine Pilot Award
Professors Harmen Bussemaker and Tuuli Lappalainen have received an inaugural Roy and Diana Vagelos Precision Medicine Pilot Award for a collaboration to elucidate the tissue-specific molecular mechanisms underlying disease associations through genetic variation analysis and molecular network data.
Organoids Created from Patients’ Bladder Cancers Could Guide Treatment
A study, led by Professor Michael Shen, published in Cell, details the development of patient-specific bladder cancer organioids that mimic many of the characteristics of actual tumors. The use of organoids may be useful in the future to guide treatment of patients.
New Resource for Controlling Gene Expression in Bacteria
Advances in synthetic biology have already spurred innovation in the areas of drug development, chemical production and health diagnostics. To help push the field even further, and potentially at a more rapid pace, a new, comprehensive resource devised by Columbia University researchers will help synthetic biologists better engineer designs for complex biological systems.
Harris Wang Named 2018 Schaefer Scholar
Dr. Wang has been named a Schaefer Research Scholar for his novel approach to explore the role that bacteria cells in our gastrointestinal tract play on the efficacy of drug therapies. Columbia University's Schaefer Scholars program honors outstanding researchers in the field of human physiology.
Precision Oncology: New Tests Look Beyond Genes
Two new precision medicine tests, born out of research from the Califano Lab, have just received New York State Department of Health approval and are available to oncologists and cancer researchers for the front lines of patient care.